No takes yet. Share an insight, caveat, or question.
Preclinical study reveals that altering FoxO1 phosphorylation via PP2A inhibition preserves regulatory T cell function ex vivo, suggesting standard assays may not fully reflect in vivo phenotypes.
Penberthy et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: